价值医疗导向下美国GPO增值服务的发展历程、实践路径及对我国的启示  

The Development History,Practice Path and Enlightenment of Value-added Services of American GPO under the Guidance of Value Medicine

作　　者：王莹 姜巍 沙卓娃 魏立丰 周爽 李元亨 张港玉 Ermakov Vsevolod Rajesh Prasad Yadav Demuyakor Isaac 焦明丽[1] WANG Ying;JIANG Wei;SHA Zhuo-wa(Harbin Medical University,Harbin,150081,China;不详)

机构地区：[1]哈尔滨医科大学卫生管理学院,哈尔滨150081 [2]国家卫生健康委卫生发展研究中心,北京100191 [3]哈尔滨医科大学第二附属医院,哈尔滨150086

出　　处：《中国卫生经济》2022年第3期93-96,共4页Chinese Health Economics

基　　金：国家社会科学基金重点项目(20STA072);美国CHINA MEDICAL BOARD(CMB)项目(Grant19-309);国家卫生健康委卫生发展研究中心,发达国家卫生财政投入机制对我国的启示项目(0146-22992200013);中国卫生经济学会,美国GPO运行机制对中国的启示研究项目(2209299);黑龙江省双规划编制与评估项目。

摘　　要：通过对“价值医疗”和美国GPO的内在逻辑进行分析,梳理美国价值医疗导向下GPO提供增值服务为医疗机构实现的效能;包括:物流价值、管理价值、技术价值、服务价值。文章结合我国集采的实际情况,从单纯追求成本节约向价值导向转变、探索多元化的药品采购主体、培养基于战略需求的增值服务进而提高医疗机构的服务效能3个方面为我国的医疗卫生领域集采优化提供借鉴和参考。Through the analysis of the internal logic of "Value Medical" and the American Group Purchasing Organization(GPO),it combs the effectiveness of GPO providing value-added services for medical institutions under the guidance of value-based medicine,including logistics value,management value,technical value and service value.Combined with the centralized procurement situation in China,it provides references for the optimization of centralized procurement in China’s medical and health field from three aspects:the simple pursuit of cost saving to value orientation,exploring diversified drug procurement subjects,cultivating value-added services based on strategic needs,and then improving the service efficiency of medical institutions.

关 键 词：价值医疗 美国GPO 增值服务 

分 类 号：R1—9[医药卫生—公共卫生与预防医学] F019.6[经济管理—政治经济学]